$2.41
-0.0041-0.17%
At Close: -
$2.38
-0.03-1.08%
After Hours: Jul 8, 8:06 AM EDT
15 minutes delayed
InspireMD
NSPRNASDAQ
InspireMD (NASDAQ:NSPR) Stock, Analyst Ratings, Price Targets, Forecasts
InspireMD Inc has a consensus price target of $4.8 based on the ratings of 4 analysis. The 3 most-recent analyst ratings were released by Piper Sandler, Piper Sandler, and National Alliance Securities on November 2, 2023, June 12, 2023, and May 17, 2023, respectively. With an average price target of $4.08 between Piper Sandler, Piper Sandler, and National Alliance Securities, there's an implied 71.57% upside for InspireMD Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
National Alliance Securities
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for InspireMD
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/02/2023 | Buy Now | 89.08% | Piper Sandler | Adam Maeder | $3.5 → $4.5 | Maintains | Overweight | Get Alert |
| 06/12/2023 | Buy Now | 26.05% | Piper Sandler | Adam Maeder | → $3 | Initiates | → Overweight | Get Alert |
| 05/17/2023 | Buy Now | 99.58% | National Alliance Securities | Ben Haynor | $5.15 → $4.75 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 116.39% | Alliance Global Partners | Ben Haynor | $5.6 → $5.15 | Maintains | Buy | Get Alert |
FAQ
What is the target price for InspireMD (NSPR) stock?
The latest price target for InspireMD (NASDAQ:NSPR) was reported by Piper Sandler on November 2, 2023. The analyst firm set a price target for $4.50 expecting NSPR to rise to within 12 months (a possible 89.08% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for InspireMD (NSPR)?
The latest analyst rating for InspireMD (NASDAQ:NSPR) was provided by Piper Sandler, and InspireMD maintained their overweight rating.
When was the last upgrade for InspireMD (NSPR)?
There is no last upgrade for InspireMD
When was the last downgrade for InspireMD (NSPR)?
There is no last downgrade for InspireMD.
When is the next analyst rating going to be posted or updated for InspireMD (NSPR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InspireMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InspireMD was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating InspireMD (NSPR) correct?
While ratings are subjective and will change, the latest InspireMD (NSPR) rating was a maintained with a price target of $3.50 to $4.50. The current price InspireMD (NSPR) is trading at is $2.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.